Connexin and Pannexin Hemichannels: Broad‐Spectrum Players in Neuroinflammatory Signaling
Journal of Neurochemistry · 2025-09 · 169 (9)
DOI: 10.1111/jnc.70237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, online erschienen am 16.09.2025. Verfasst von Juan C Sáez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Neurociencias, Centro Interdisciplinario de Neurociencias, Universidad de Valparaíso, Valparaíso, Chile. Hauptthemen laut MEDLINE: Connexins, Neuroinflammatory Diseases, Signal Transduction, Nerve Tissue Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 265 Literaturangaben. Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico.
Abstract (Originalsprache)
Connexin‐ and pannexin‐formed hemichannels have emerged as pivotal, upstream amplifiers of neuroinflammation. Under physiological stressors—depolarization, Ca 2+ overload, redox shift, or cytokine exposure—these large pores release adenosine triphosphate, glutamate, and other danger signals that activate P2X/P2Y and N‐methyl‐D‐aspartate receptors, ignite NLR family pyrin domain containing (NLRP) 3 inflammasome, and propagate Ca 2+ /reactive oxygen species waves between mast cells, microglia, astrocytes, oligodendrocytes, neurons, and brain endothelium. Evidence across acute (e.g., stroke, trauma, seizure, and sepsis) and chronic (e.g., Alzheimer's, and multiple sclerosis) models shows that genetic ablation or pharmacological blockade of hemichannels shrinks lesions, preserves synaptic plasticity, restores blood–brain barrier integrity, and rescues cognition, often without altering the primary pathogenic trigger. Translational leads include mimetic peptides (e.g., Gap19, 10 panx1), the nanomolar, gap junction–sparing small‐molecule D4, and the pleiotropic alkaloid boldine, all of which curb epileptiform activity, neurodegeneration, and depressive‐like behavior. Yet key gaps persist, such as the long‐term safety of chronic inhibition, which remains poorly defined and will be critical to translate these “gatekeeper” channels into next‐generation neuro–anti‐inflammatory therapeutics. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Neurociencias, Centro Interdisciplinario de Neurociencias, Universidad de Valparaíso, Valparaíso, Chile.
- Departamento de Neurología, Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
ORCID-Profile: Juan A Orellana
Förderung
- Fondo Nacional de Desarrollo Científico y Tecnológico
Zitieren
APA
Sáez, J. C., Ocaranza, F. J., Prieto-Villalobos, J., & Orellana, J. A. (2025). Connexin and Pannexin Hemichannels: Broad‐Spectrum Players in Neuroinflammatory Signaling. Journal of Neurochemistry, 169(9). https://doi.org/10.1111/jnc.70237
Vancouver
Sáez JC, Ocaranza FJ, Prieto-Villalobos J, Orellana JA. Connexin and Pannexin Hemichannels: Broad‐Spectrum Players in Neuroinflammatory Signaling. Journal of Neurochemistry. 2025;169(9). doi:10.1111/jnc.70237
BibTeX
@article{Sez2025,
author = {Sáez, Juan C and Ocaranza, Francisco J and Prieto-Villalobos, Juan and Orellana, Juan A},
title = {Connexin and Pannexin Hemichannels: Broad‐Spectrum Players in Neuroinflammatory Signaling},
journal = {Journal of Neurochemistry},
year = {2025},
volume = {169},
number = {9},
doi = {10.1111/jnc.70237}
}
EUVIMED